{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:44:23Z","timestamp":1748270663793},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11864-020-0724-4","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T11:03:34Z","timestamp":1584615814000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["How to Use Methadone in an Era of an Opioid Epidemic"],"prefix":"10.1007","volume":"21","author":[{"given":"Yvonne","family":"Heung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhila","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"724_CR1","first-page":"1","volume":"329","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Minino AM, Warner M. Drug overdose deaths in the United States, 1999-2017. NCHS Data Brief. 2018;329:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"5152","key":"724_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2018","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths-United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419\u201327.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"724_CR3","unstructured":"Murthy V. Letter from United States surgeon general Vivek H. Murthy, MD, MBA 2016 available from: http:\/\/i2.cdn.turner.com\/cnn\/2016\/images\/08\/25\/sg.opioid.letter.pdf. Letter from U.S. Surgeon General call to action in response of opioid crisis."},{"issue":"15","key":"724_CR4","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"\u2022\u2022 Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624\u201345 CDC guidelines for prescribing opioids in chronic pain.","journal-title":"JAMA"},{"issue":"8","key":"724_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1634\/theoncologist.2015-0503","volume":"21","author":"J Porta-Sales","year":"2016","unstructured":"Porta-Sales J, Garzon-Rodriguez C, Villavicencio-Chavez C, Llorens-Torrome S, Gonzalez-Barboteo J. Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist. 2016;21(8):981\u20137.","journal-title":"Oncologist"},{"issue":"11","key":"724_CR6","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1089\/jpm.2013.0222","volume":"16","author":"W Rhondali","year":"2013","unstructured":"Rhondali W, Tremellat F, Ledoux M, Ciais JF, Bruera E, Filbet M. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study. J Palliat Med. 2013;16(11):1382\u20137.","journal-title":"J Palliat Med"},{"issue":"8","key":"724_CR7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","volume":"12","author":"S Mercadante","year":"2008","unstructured":"Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (London, England). 2008;12(8):1040\u20136.","journal-title":"Eur J Pain (London, England)"},{"issue":"6","key":"724_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1089\/jpm.2016.0316","volume":"20","author":"A Reddy","year":"2017","unstructured":"Reddy A, Schuler US, de la Cruz M, Yennurajalingam S, Wu J, Liu D, et al. Overall survival among cancer patients undergoing opioid rotation to methadone compared to other opioids. J Palliat Med. 2017;20(6):656\u201361.","journal-title":"J Palliat Med"},{"issue":"12","key":"724_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.15585\/mmwr.mm6612a2","volume":"66","author":"M Faul","year":"2017","unstructured":"Faul M, Bohm M, Alexander C. Methadone prescribing and overdose and the association with Medicaid preferred drug list policies-United States, 2007-2014. MMWR Morb Mortal Wkly Rep. 2017;66(12):320\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"724_CR10","first-page":"Cd003971","volume":"2","author":"AB Nicholson","year":"2017","unstructured":"\u2022\u2022 Nicholson AB, Watson GR, Derry S, Wiffen PJ. Methadone for cancer pain. Cochrane Database Syst Rev. 2017;2:Cd003971 Systematic review on use of methadone for cancer pain.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"724_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","volume":"15","author":"R Chou","year":"2014","unstructured":"\u2022\u2022 Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on problems of drug dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15(4):321\u201337 American Pain Society guidelines on use of methadone for chronic pain.","journal-title":"J Pain"},{"issue":"3","key":"724_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"\u2022\u2022 McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manag. 2019;57(3):635\u201345.e4 Guidelines on use of methadone in the hospice and palliative care setting.","journal-title":"J Pain Symptom Manag"},{"key":"724_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5935\/1806-0013.20150012","volume":"16","author":"JO Barbosa Neto","year":"2015","unstructured":"Barbosa Neto JO, Garcia MA, Garcia JBS. Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication. Rev Dor. 2015;16:60\u20136.","journal-title":"Rev Dor"},{"issue":"3","key":"724_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain medicine (Malden, Mass). 2008;9(3):315\u201344.","journal-title":"Pain medicine (Malden, Mass)"},{"issue":"2","key":"724_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/NNR.0000000000000204","volume":"66","author":"Z Zahari","year":"2017","unstructured":"Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, et al. ABCB1 polymorphisms and cold pressor pain responses: opioid-dependent patients on methadone maintenance therapy. Nurs Res. 2017;66(2):134\u201344.","journal-title":"Nurs Res"},{"issue":"Suppl","key":"724_CR16","first-page":"8","volume":"17","author":"Z Zahari","year":"2018","unstructured":"Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, et al. Relationship between serum methadone concentration and cold pressor pain sensitivity in patients undergoing methadone maintenance therapy. Iran J Pharm Res. 2018;17(Suppl):8\u201316.","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"724_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","volume":"223","author":"AL Gorman","year":"1997","unstructured":"Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223(1):5\u20138.","journal-title":"Neurosci Lett"},{"issue":"6","key":"724_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/jpm.2012.0612","volume":"16","author":"SR Salpeter","year":"2013","unstructured":"\u2022 Salpeter SR, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013;16(6):616\u201322. Use of methadone in unique circumstance opioid-induced hyperalgesia.","journal-title":"J Palliat Med"},{"issue":"2","key":"724_CR19","first-page":"1048","volume":"289","author":"AM Davis","year":"1999","unstructured":"Davis AM, Inturrisi CE. D-methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther. 1999;289(2):1048\u201353.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"724_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1124\/jpet.102.035881","volume":"303","author":"EA Bolan","year":"2002","unstructured":"Bolan EA, Tallarida RJ, Pasternak GW. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther. 2002;303(2):557\u201362.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"724_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0014-2999(98)00366-5","volume":"351","author":"A Chang","year":"1998","unstructured":"Chang A, Emmel DW, Rossi GC, Pasternak GW. Methadone analgesia in morphine-insensitive CXBK mice. Eur J Pharmacol. 1998;351(2):189\u201391.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"724_CR22","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1172\/JCI126912","volume":"129","author":"NS Cai","year":"2019","unstructured":"Cai NS, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, et al. Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. J Clin Invest. 2019;129(7):2730\u201344.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"724_CR23","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.4103\/IJPC.IJPC_180_17","volume":"24","author":"MM Sunilkumar","year":"2018","unstructured":"Sunilkumar MM, Lockman K. Practical pharmacology of methadone: a long-acting opioid. Indian J Palliat Care. 2018;24(Suppl 1):S10\u2013s4.","journal-title":"Indian J Palliat Care"},{"key":"724_CR24","first-page":"Cd012499","volume":"5","author":"ED McNicol","year":"2017","unstructured":"McNicol ED, Ferguson MC, Schumann R. Methadone for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;5:Cd012499.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"724_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/jpm.2016.0411","volume":"20","author":"KM Juba","year":"2017","unstructured":"Juba KM, Khadem TM, Hutchinson DJ, Brown JE. Methadone and corrected QT prolongation in pain and palliative care patients: a case-control study. J Palliat Med. 2017;20(7):722\u20138.","journal-title":"J Palliat Med"},{"issue":"4","key":"724_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/00952990.2013.804525","volume":"39","author":"A Fareed","year":"2013","unstructured":"Fareed A, Vayalapalli S, Scheinberg K, Gale R, Casarella J, Drexler K. QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study. Am J Drug Alcohol Abuse. 2013;39(4):235\u201340.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"724_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1472-8206.2010.00871.x","volume":"25","author":"A Perrin-Terrin","year":"2011","unstructured":"Perrin-Terrin A, Pathak A, Lapeyre-Mestre M. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundam Clin Pharmacol. 2011;25(4):503\u201310.","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"724_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1526-4637.2007.00343.x","volume":"9","author":"LR Webster","year":"2008","unstructured":"Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med (Malden, Mass). 2008;9(4):425\u201332.","journal-title":"Pain Med (Malden, Mass)"},{"issue":"3","key":"724_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jpainsymman.2017.10.017","volume":"55","author":"S Mercadante","year":"2018","unstructured":"\u2022 Mercadante S, Bruera E. Methadone as a first-line opioid in cancer pain management: a systematic review. J Pain Symptom Manag. 2018;55(3):998\u20131003. Use of methadone as a first-line opioid.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"724_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","volume":"50","author":"S McLean","year":"2015","unstructured":"\u2022\u2022 McLean S, Twomey F. Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manag. 2015;50(2):248\u201359.e1 Successful use of methadone per Expert Consensus White Paper guidelines.","journal-title":"J Pain Symptom Manag"},{"issue":"1\u20132","key":"724_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/15360288.2019.1629521","volume":"33","author":"D Trofimovitch","year":"2019","unstructured":"Trofimovitch D, Hutchinson L, Baumrucker SJ. Preliminary validation for the \u201cBJR method\u201d-a possible new mathematical approach to methadone conversion. J Pain Palliat Care Pharmacother. 2019;33(1\u20132):42\u20138.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"724_CR32","doi-asserted-by":"crossref","unstructured":"Smith MA, Quirk KC, Saul DC, Rodgers PE, Silveira MJ. Comparing methadone rotation to consensus opinion. J Pain Symptom Manag. 2019; Successful use of methadone per Expert Consensus White Paper guidelines.","DOI":"10.1016\/j.jpainsymman.2019.09.014"},{"issue":"16","key":"724_CR33","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.ejca.2011.06.047","volume":"47","author":"K Moksnes","year":"2011","unstructured":"\u2022 Moksnes K, Dale O, Rosland JH, Paulsen O, Klepstad P, Kaasa S. How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trial. Eur J Cancer (Oxford, England: 1990). 2011;47(16):2463\u201370. Superiority of three-day switch method for initiating higher-dose methadone.","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"724_CR34","doi-asserted-by":"crossref","unstructured":"Chalker C, O'Neill H, Cranfield F. Efficacy of low-dose and\/or adjuvant methadone in palliative medicine. BMJ Support Palliat Care. 2019.","DOI":"10.1136\/bmjspcare-2018-001695"},{"issue":"4","key":"724_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5055\/jom.2013.0167","volume":"9","author":"MH van den Beuken-van Everdingen","year":"2013","unstructured":"van den Beuken-van Everdingen MH, Geurts JW, Patijn J. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain. J Opioid Manag. 2013;9(4):263\u20137.","journal-title":"J Opioid Manag"},{"issue":"10","key":"724_CR36","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/0003-4819-158-10-201305210-00008","volume":"158","author":"D Kao","year":"2013","unstructured":"Kao D, Bucher Bartelson B, Khatri V, Dart R, Mehler PS, Katz D, et al. Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data. Ann Intern Med. 2013;158(10):735\u201340.","journal-title":"Ann Intern Med"},{"issue":"6","key":"724_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/ADM.0000000000000353","volume":"11","author":"G Bart","year":"2017","unstructured":"\u2022\u2022 Bart G, Wyman Z, Wang Q, Hodges JS, Karim R, Bart BA. Methadone and the QTc interval: paucity of clinically significant factors in a retrospective cohort. J Addict Med. 2017;11(6):489\u201393 QTc prolongation in not significant and cardiac events are rare.","journal-title":"J Addict Med"},{"issue":"1","key":"724_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/jpm.2009.0184","volume":"13","author":"S Reddy","year":"2010","unstructured":"\u2022\u2022 Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, et al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010;13(1):33\u20138 No evidence of clincially significant arrhythmias.","journal-title":"J Palliat Med"},{"issue":"5","key":"724_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpainsymman.2007.11.003","volume":"36","author":"RA Cruciani","year":"2008","unstructured":"Cruciani RA. Methadone: to ECG or not to ECG...That is still the question. J Pain Symptom Manag. 2008;36(5):545\u201352.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"724_CR40","first-page":"135","volume":"94","author":"RL Brown","year":"1995","unstructured":"Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94(3):135\u201340.","journal-title":"Wis Med J"},{"issue":"19","key":"724_CR41","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1002\/cncr.31670","volume":"124","author":"S Yennurajalingam","year":"2018","unstructured":"\u2022\u2022 Yennurajalingam S, Edwards T, Arthur JA, Lu Z, Najera J, Nguyen K, et al. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center. Cancer. 2018;124(19):3942\u20139. Approaches to care for patients with risk of non-medical opioid use.","journal-title":"Cancer"},{"issue":"2","key":"724_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6\u20139.","journal-title":"J Palliat Care"},{"issue":"1","key":"724_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1634\/theoncologist.2016-0266","volume":"22","author":"M de la Cruz","year":"2017","unstructured":"\u2022\u2022 de la Cruz M, Reddy A, Balankari V, Epner M, Frisbee-Hume S, Wu J, et al. The impact of an educational program on patient practices for safe use, storage, and disposal of opioids at a comprehensive cancer center. Oncologist. 2017;22(1):115\u201321 Use of educational program to promote safe handling of opioids.","journal-title":"Oncologist"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-0724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-020-0724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-0724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T01:20:22Z","timestamp":1616116822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-020-0724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s11864-020-0724-4","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"assertion":[{"value":"19 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Yvonne Heung declares that she has no conflict of interest.Akhila Reddy declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"30"}}